1. Home
  2. GPRO vs VYGR Comparison

GPRO vs VYGR Comparison

Compare GPRO & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoPro Inc.

GPRO

GoPro Inc.

N/A

Current Price

$0.96

Market Cap

214.6M

ML Signal

N/A

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

N/A

Current Price

$1.72

Market Cap

193.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GPRO
VYGR
Founded
2004
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
214.6M
193.5M
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
GPRO
VYGR
Price
$0.96
$1.72
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
★ $14.89
AVG Volume (30 Days)
★ 6.0M
949.4K
Earning Date
11-09-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 79.08
N/A
EPS
★ N/A
N/A
Revenue
★ $651,542,000.00
$10,135,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$35.48
$129.75
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.57
$1.70
52 Week High
$2.05
$5.19

Technical Indicators

Market Signals
Indicator
GPRO
VYGR
Relative Strength Index (RSI) 33.60 29.21
Support Level $0.94 N/A
Resistance Level $1.17 $2.29
Average True Range (ATR) 0.06 0.15
MACD -0.02 0.00
Stochastic Oscillator 4.01 2.91

Price Performance

Historical Comparison
GPRO
VYGR

About GPRO GoPro Inc.

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: